Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

5-benzyloxytryptamine: a relatively selective 5-hydroxytryptamine 1D/1B agent.

S J Peroutka1, B G McCarthy, X M Guan

  • 1Department of Neurology, Stanford University School of Medicine, CA 94305.

Life Sciences
|January 1, 1991
PubMed
Summary

Researchers analyzed nineteen tryptamine derivatives for 5-hydroxytryptamine1D (5-HT1D) receptor interactions. 5-benzyloxytryptamine (5-BT) emerged as a selective partial agonist, showing distinct binding and functional profiles at 5-HT1D receptors.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Demographic Analysis of Industry-Sponsored Alzheimer's Disease Trial Populations in the United States.

The journal of prevention of Alzheimer's disease·2023
Same author

[Analysis of children infected with varicella-zoster virus after hematopietic steam cell transplantation].

Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi·2022
Same author

[Prognosis of the central nervous system involvement in patients with hemophagocytic lymphohistiocytosis].

Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi·2017
Same author

[X-linked lymphoproliferative syndrome type 1 complicated with secondary hemophagocytic lymphohistiocytosis and ileal perforation: case report and literature review].

Zhonghua er ke za zhi = Chinese journal of pediatrics·2016
Same author

"Specific" [(3)H]8-OH-DPAT binding to glass fiber filter paper: Implications for the analysis of serotonin binding site subtypes.

Neurochemistry international·2010
Same author

About the so-called specific binding of [(3)H]8-OH-DPAT to glass fiber filter.

Neurochemistry international·2010

Area of Science:

  • Pharmacology
  • Neuroscience
  • Medicinal Chemistry

Background:

  • The 5-hydroxytryptamine1D (5-HT1D) receptor is a key target in neurological research.
  • Understanding tryptamine derivative interactions with 5-HT1D receptors is crucial for drug development.

Purpose of the Study:

  • To investigate the binding affinities and functional activities of nineteen tryptamine derivatives at 5-HT1D receptor sites.
  • To characterize the pharmacological profile of 5-benzyloxytryptamine (5-BT) in relation to 5-HT1D receptors.

Main Methods:

  • Radioligand binding assays were performed using bovine caudate to assess competition with known ligands for 5-HT1D receptor sites.
  • Functional studies involved measuring the inhibition of 3H-5-HT release from guinea pig cortical synaptosomes.

Related Experiment Videos

Main Results:

  • Sixteen of nineteen tryptamine derivatives competed for 5-HT1D receptor binding sites with Hill slopes near unity.
  • 5-carboxyamidotryptamine (5-CT), sumatriptan, and 5-benzyloxytryptamine (5-BT) exhibited Hill slopes significantly less than unity, suggesting distinct binding mechanisms.
  • 5-BT demonstrated relative selectivity for 5-HT1D/1B binding sites and acted as a partial agonist, inhibiting 3H-5-HT release with lower efficacy than sumatriptan.

Conclusions:

  • 5-BT displays characteristics of a selective partial agonist at 5-HT1D receptors.
  • The substitution pattern at the 5-position of the indole moiety influences the interaction with 5-HT1D receptors.
  • These findings contribute to the understanding of 5-HT1D receptor pharmacology and potential therapeutic applications.